MLchartDataset catalogue

SERD

Term · Oncology and biomedicine · MLC-T-ONC-007677

A drug that binds to and breaks down proteins called estrogen receptors (ERs), which are found inside the cells of female reproductive tissue, breast tissue, and other types of tissue, and some cancer cells. These drugs keep the hormone estrogen from binding to the ERs inside the cells and block the effects of estrogen in the body. Some breast cancer cells and other types of cancer cells have ERs and may need estrogen to grow. Treatment with SERDs may keep these cancer cells from growing. Examples of SERDs that have been approved to treat some types of breast cancer are fulvestrant and elacestrant. Also called selective estrogen receptor degrader.

Table 1. Record
IdentifierMLC-T-ONC-007677
FieldOncology and biomedicine
Expansionsselective estrogen receptor degrader
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007677",
  "term": "SERD",
  "field": "Oncology and biomedicine",
  "definition": "A drug that binds to and breaks down proteins called estrogen receptors (ERs), which are found inside the cells of female reproductive tissue, breast tissue, and other types of tissue, and some cancer cells. These drugs keep the hormone estrogen from binding to the ERs inside the cells and block the effects of estrogen in the body. Some breast cancer cells and other types of cancer cells have ERs and may need estrogen to grow. Treatment with SERDs may keep these cancer cells from growing. Examples of SERDs that have been approved to treat some types of breast cancer are fulvestrant and elacestrant. Also called selective estrogen receptor degrader.",
  "expansions": [
    "selective estrogen receptor degrader"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/serd/"
}

Record 14,853 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.